This program focuses on the management of life-threatening bleeds from a range of specialties: Emergency Medicine, Neurocritical Care, Trauma, and Gastroenterology. A panel of international Emergency Medicine experts will provide perspectives on each of the associated areas of bleeding and relevant clinical cases.

As the utilization of direct oral anticoagulants (DOACs) increases, there is a parallel increase in major bleeding events, especially ICH.

This program covers management of life-threatening bleeding of anticoagulated patients and the use of reversal/repletion agents in critical access hospitals.

As the utilization of direct oral anticoagulants (DOACs) increases, there is a parallel increase in major bleeding events, especially intracranial hemorrhages, requiring hospitalization. Clinicians are not recognizing or distinguishing major from minor bleeding or appropriately employing emergent options to manage major bleeding.

As the utilization of direct oral anticoagulants (DOACs) increases, there is a parallel increase in major bleeding events, especially intracranial hemorrhages, requiring hospitalization. Clinicians are not recognizing or distinguishing major from minor bleeding, or appropriately employing emergent options to manage major bleeding. Recent solutions for DOAC related life-threatening bleeding are under-recognized and under-utilized solutions for patients with these life-threatening emergencies. Over the last 12-18 months, nationally recognized guidelines have provided clear direction on how best to manage these types of major bleeding events.

As the utilization of direct oral anticoagulants (DOACs) increases, there is a parallel increase in major bleeding events, especially intracranial hemorrhages, requiring hospitalization. Clinicians are not recognizing or distinguishing major from minor bleeding, or appropriately employing emergent options to manage major bleeding. Recent solutions for DOAC related life-threatening bleeding are under-recognized and under-utilized solutions for patients with these life-threatening emergencies.

The impact of the ever-changing COVID-19 pandemic is creating a rapidly evolving clinical environment for healthcare providers (HCPs). HCPs are challenged to keep up with the most current clinical information, while constantly evolving their approaches to the management of patients with acute ischemic stroke or transient ischemic attacks (TIA). As a result, innovative approaches are required to educate HCPs on how they can make a positive impact on patient care and improve clinical outcomes in the new COVID-19 world, especially as it relates to emergency medicine.

This program has a particular focus on patients with COVID-19, and how to approach anticoagulation with them. Hear from leading emergency medicine experts on their perspectives of how to manage these unique situations.

As the utilization of direct oral anticoagulants (DOACs) increases, there is a parallel increase in major bleeding events, especially intracranial hemorrhages, requiring hospitalization. Clinicians are not recognizing or distinguishing major from minor bleeding, or appropriately employing emergent options to manage major bleeding. Recent solutions for DOAC related life-threatening bleeding are under-recognized and under-utilized solutions for patients with these life-threatening emergencies.

The current approach and disease indications for treatment with anticoagulants such as coumadin, Factor IIa, and Factor Xa inhibitors are particularly relevant. This program is highlighted by the presentation of cases managed by experts in emergency medicine, critical care medicine, hospital medicine, and trauma surgery.

Join Natalie Kreitzer, MD, MS, take you through a step-by-step approach to managing this life-threatening condition in your ED.

As the utilization of direct oral anticoagulants (DOACs) increase, there is a parallel increase in major bleeding events, especially intracranial hemorrhages, requiring hospitalization. Clinicians are not recognizing or distinguishing major from minor bleeding, or appropriately employing emergent options to manage major bleeding.

Clinicians participating in this program and caring for patients suffering from hyperkalemia will be better prepared to understand the role of the various oral binding agents.

Through this critical care approach to the evaluation and treatment of life-threatening bleeding in anti-coagulated patients, clinicians caring for these patients in the acute care setting (ED and ICU) will be better prepared to manage them.

This EMCREG-International On the Go program serves as a sharing of interdisciplinary best practices of how to optimize and improve the current management of venous thromboembolism (VTE) and the consistent transition of care for practicing physicians, nurses, and pharmacists.

This EMCREG-International On the Go program serves as a sharing of interdisciplinary best practices of how to optimize and improve the current management of venous thromboembolism (VTE) and the consistent transition of care for practicing physicians, nurses, and pharmacists.

Through this critical care approach to the evaluation and treatment of acute kidney injury (AKI) and resulting hyperkalemia, clinicians caring for these patients in the acute care setting (ED and ICU) will be better prepared to mitigate further kidney injury and treat life-threatening hyperkalemia.

Expert faculty from the University of Cincinnati College of Medicine review major and minor bleeds, key considerations and recommendations associated with reversal agents for DOACs, and employing swift treatment strategies within the emergency department.

This site leverages the international experts of EMCREG-International to analyze key datasets, provide opinion on the practice of emergency medicine, thrombosis, acute cardiovascular emergencies, acute neurovascular emergencies and critical care, and debate key issues important to practice.

This program takes a case-based approach in understanding the challenges associated with the management of acute ischemic strokes in the emergency department, and covers measures and interventions which can be implemented to improve outcomes.